Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Yale Steroid Enhanced Versus Exparel Nerveblock TKA Randomized Controlled Trial (RCT) Study

NCT05279092 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05279092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05279092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Yale Steroid Enhanced Versus Exparel Nerveblock TKA Randomized Controlled Trial (RCT) Study
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Recruiting
Start date
September 8, 2022
Completion date
March 31, 2028
Enrollment
250 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

knee arthroplasty, total knee replacement